Comparison of HPA axis hormonal responses to naloxone vs psychologically-induced stress

Psychoneuroendocrinology

Volumn 29, Issue 3, 2004, Pages 371-388

  Oswald, Lynn M ^a   Mathena, Joanna R ^a   Wand, Gary S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenocorticotropin; Cortisol; Naloxone; Opioid peptides; Personality; Stress psychological

Indexed keywords

CORTICOTROPIN; NALOXONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DRUG RESPONSE; FEMALE; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MENTAL STRESS; NORMAL HUMAN; NOVELTY SEEKING BEHAVIOR; PERSONALITY; PREDICTION; PRIORITY JOURNAL; SOCIAL PROBLEM;

EID: 0345276430     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(03)00048-9     Document Type: Article

References (64)

1. al' Absi M., Bongard S., Lovallo W.R. Adrenocorticotropin responses to interpersonal stress: effects of overt anger expression style and defensiveness. Int. J. Psychophysiol. 37:2000;257-265.
2. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. 1994;Author, Washington, DC.
3. Beck A.T. Beck Depression Inventory. 1987;The Psychological Corporation, New York.
4. Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities? Obes. Rev. 2:2001;73-86.
5. Bohnen N., Nicolson N., Sulon J., Jolles J. Coping style, trait anxiety and cortisol reactivity during mental stress. J. Psychosom. Res. 35:1991;141-147.
6. Bucholz K.K., Cadoret R., Cloninger D.R., Dinwiddie S.H.E., Hesselbrock V.M., Numberger J.I. Jr., Reich T., Schmidt I., Schuckit M.A. A new semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J. Stud. Alcohol. 55:1994;149-158.
7. Bujdoso E., Jaszberenyi M., Tomboly C., Toth G., Telegdy G. Behavioral and neuroendocrine actions of endomorphin-2. Peptides. 22:2001;1459-1463.
8. Calogero A.E. Neurotransmitter regulation of the hypothalamic corticotropin-releasing hormone neuron. Ann. N.Y. Acad. Sci. 771:1995;31-40.
9. Chrousos G.P. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int. J. Obesity. 24:(Suppl. 2):2000;S50-S55.
10. Chrousos G.P., Gold P.W. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA. 267:1992;1244-1262.
11. Cohen M.R., Pickar D., Dubois M. The role of the endogenous opioid system in the human stress response. Psychiatr. Clin. North Am. 6:1983;457-471.
12. Costa P.T. Jr., McCrae R.R. Normal personality assessment in clinical practice: the NEO Personality Inventory. Psychol. Assess. 4:1992;5-13.
13. Costa P.T. Jr, McCrae R.R. Revised NEO Personality Inventory: Professional Manual. 1992;Psychological Assessment Resources, Odessa, FL.
14. del Campo A.F.M., Dowson J.H., Herbert J., Paykel E.S. Effects of naloxone on diurnal rhythms in mood and endocrine function: a dose-response study in man. Psychopharmacology. 114:1994;583-590.
15. del Campo A.F.M., McMurray R.G., Besser G.M., Grossman A. Effect of 12-hour infusion of naloxone on mood and cognition in normal male volunteers. Biol. Psychiatry. 32:1992;344-353.
16. Derogatis L.R. SCL-90-R Administration, Scoring, and Procedures Manual. 1977;National Computer Systems, Minneapolis, MN.
17. Derogatis L.R., Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol. Med. 13:1993;595-605.
18. Djurovic D., Milic-Askrabic J., Majkic-Singh N. Serum beta-endorphin level in patients with depression on fluvoxamine. Farmaco. 54:1999;130-133.
19. Drolet G., Dumont E.C., Gosselin I., Kinkead R., LaForest S., Trottier J.F. Role of endogenous opioid system in the regulation of the stress response. Prog. Neuro-Psycholpharmacol. Biol. Psychiatry. 25:2001;729-741.
20. Ebstein R.P., Benjamin J., Belmaker R.H. Personality and polymorphism of genes involved in aminergic neurotransmission. Eur. J. Pharmacol. 410:2000;205-214.
21. Facchinetti F., Fioroni L., Martignoni E., Sances G., Costa A., Genazzani A.R. Changes of opioid modulation of the hypothalamo-pituitary- adrenal axis in patients with severe premenstrual syndrome. Psychosom. Med. 56:1994;418-422.
22. Gerra G., Zaimovic A., Timpano M., Zambelli U., Delsignore R., Brambilla F. Neuroendocrine correlates of temperamental traits in humans. Psychoneuroendocrinology. 25:2000;479-496.
23. Gianoulakis C. Implications of endogenous opioids and dopamine in alcoholism: Human and basic science studies. Alcohol Alcohol. 31:(Suppl. 1):1996;33-42.
24. Grossi G., Ahs A., Lundberg U. Psychological correlates of salivary cortisol secretion among unemployed men and women. Integr. Physiol. Behav. Sci. 33:1998;249-263.
25. Grossman A., Besser G.M. Opiates control ACTH through a noradrenergic mechanism. Clin. Endocrinology. 17:1982;287-290.
26. Heim C., Newport D.J., Wagner D., Wilcox M.M., Miller A.H., Nemeroff C.B. The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: a multiple regression analysis. Depress. Anxiety. 15:2002;117-125.
27. Heim C., Newport D.J., Bonsall R., Miller A.H., Nemeroff C.B. Altered pituitary-adrenal axis responses to provocative challenge test in adult survivors of childhood abuse. Am. J. Psychiatry. 158:2001;575-581.
28. Janssens C.J.J.G., Helmond F.A., Loyens L.W., Schouten W.G.P., Wiegant V.M. Chronic stress increases the opioid-mediated inhibition of the pituitary-adrenocortical response to acute stress in pigs. Endocrinology. 136L:1995;1468-1473.
29. Johnson E.O., Kamilaris T.C., Chrousos G.P., Gold P.W. Mechanisms of stress: a dynamic overview of hormonal and behavioral homeostasis. Neurosci. Biobehav. Rev. 16:1992;115-130.
30. Kapas S., Purbrick A., Hinson J.P. Action of opioid peptides on the rat adrenal cortex: stimulation of steroid secretion through a specific mu opioid receptor. J. Endocrinol. 144:1995;503-510.
31. Kemper A., Koalick F., Thiele H., Retzow A., Rathsack R., Nickel B. Cortisol and β-endorphin response in alcoholics and alcohol abusers following a high naloxone dosage. Drug Alcohol Depend. 25:1990;319-326.
32. Kieffer B.L., Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Prog. Neurobiol. 66:2002;285-306.
33. King A.C., Schluger J., Gunduz M., Borg L., Perret G., Ho A., Kreek M.J. Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism. Neuropsychopharmacology. 26:(778-78):2002;8.
34. Kirschbaum D., Bartussek D., Strasburger C.J. Cortisol responses to psychological stress and correlations with personality traits. Person. Individ. Diff. 13:1992;1352-1357.
35. Kirschbaum C., Pirke K., Hellhammer D.H. The 'Trier Social Stress Test' - a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology. 28:1993;76-81.
36. Koo-Loeb J.H., Costello N., Light K.C., Girdler S.S. Women with eating disorder tendencies display altered cardiovascular, neuroendocrine, and psychosocial profiles. Psychosom. Med. 62:2000;539-548.
37. Kreek M.J. Opioid receptors: some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases. Neurochem. Res. 21:1996;1469-1488.
38. Kreek M.J., Koob G.F. Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend. 51:1998;23-47.
39. Linkowski P., Van Onderbergen A., Kerkhofs M., Bosson D., Mendlewicz J., Van Cauter E. Twin study of the 24-h cortisol profile: evidence for genetic control of the human circadian clock. Am. J. Physiol. Pt 1), E173-E181. 264:(2 Pt 1):1993;E173-E181.
40. Mangold D., McCaul M.E., Ali M., Wand G.S. Plasma adrenocorticotropin responses to opioid blockade with naloxone: generating a dose-response curve in a single session. Biol. Psychiatry. 48:(310-31):2000;4.
41. McCleery J.M., Goodwin G.M. High and low neuroticism predict different cortisol responses to the combined dexamethasone-CRH test. Biol. Psychiatry. 49:2001;410-415.
42. Morgan C.A., Wang S., Rasmusson A., Hazlett G., Anderson G., Charney D.S. Relationship among plasma cortisol, catecholamines, neuropeptide Y, and human performance during exposure to uncontrollable stress. Psychosom. Med. 63:2001;412-422.
43. Pruessner J.C., Gaab J., Hellhammer D.H., Lintz D., Schommer N., Kirschbaum C. Increasing correlations between personality traits and cortisol stress responses obtained by data aggregation. Psychoneuroendocrinology. 22:1997;615-625.
44. Rommelspacher H., Smolka M., Schmidt L.G., Samochowiec J., Hoehe M.R. Genetic analysis of the μ-opioid receptor in alcohol-dependent individuals. Alcohol. 24:2001;129-135.
45. Rosenblitt J.C., Soler H., Johnson S.E., Quadagno D.M. Sensation seeking and hormones in men and women: exploring the link. Horm. Behav. 40:2001;396-402.
46. Rosmond R., Baghei F., Holm G., Bjorntorp P. Relationsips between personality disorders and anthropometry, hormones and metabolism in women. J. Endocrinol. Invest. 24:2001;159-165.
47. Roy M.P., Kirschbaum C., Steptoe A. Psychological, cardiovascular, and metabolic correlates of individual differences in cortisol stress recovery in young men. Psychoneuroendocrinology. 26:2001;375-391.
48. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry. 57:2000;925-935.
49. Schommer N.C., Kudielka B.M., Hellhammer D.H., Kirschbaum C. No evidence for a close relationship between personality traits and circadian cortisol rhythm or a single cortisol stress response. Psychol. Rep. 84:1999;840-842.
50. Scott L.V., Rathore O., Dinan T.G., Kelling, Keeling P.W.N. Pituitary-adrenal response to naloxone in non-ulcer dyspepsia: preliminary evidence for a reduction in central opioid tone. Digestion. 65:2002;67-72.
51. Sim-Selley L.J., Xiao R., Childers S.R. Anatomical distribution of sodium-dependent [3H] naloxone bindings sites in rat brain. Synapse. 35:2000;256-264.
52. Spielberger C.D. State-trait Anxiety Inventory (STAI). 1983;Mind Garden, Palo Alto, CA.
53. Taylor C.C., Wu D., Soong Y., Yee J.S., Szeto H.H. Opioid modulation of the fetal hypothalamic-pituitary-adrenal axis: the role of receptor subtypes and route of administration. J. Pharmacol. Exp. Ther. 281:1997;129-135.
54. Tsagarakis S., Rees L.H., Besser M., Grossman A. Opiate receptor subtype regulation of CRF-41 release from rat hypothalamus in vitro. Neuroendocrinology. 51:1990;599-605.
55. Vaccarino A.L., Kastin A.J. Endogenous opiates: 1999. Peptides. 21:2000;1975-2034.
56. Valentino R.J., Van Bockstaele E. Opposing regulation of the locus coeruleus by corticotropin-releasing factor and opioids: potential for reciprocal interactions between stress and opioid sensitivity. Psychopharmacology. 158:(331-34):2001;2.
57. Van Bockstaele E.J., Bajic D., Proudfit H., Valentino R.J. Topographic architecture of stress-related pathways targeting the noradrenergic locus coeruleus. Physiol. Behav. 73:2001;273-283.
58. Van Eck M.M.M., Nicolson N.A., Berkhof H., Sulon J. Individual differences in cortisol responses to a laboratory speech task and their relationship to responses to stressful daily events. Biol. Psychiatry. 43:1996;69-84.
59. Van Ree J.M., Niesink R.J.M., Wolfswinkel L.V., Ramsey N.F., Kornet M.M.W., Van Furth W.R., Vanderschuren L.J., Gerrits M.A., Van den Berg C.L. Endogenous opioids and reward. Eur. J. Pharmacol. 405:2000;89-101.
60. Wand G.S., Mangold D., Ali M. Adrenocorticotropin responses to naloxone in sons of alcohol-dependent men. J. Clin. Endocrinol. Metab. 84:1999;64-68.
61. Wand G.S., McCaul M.E., Gotjen D., Reynolds J., Lee S. Confirmation that offspring from families with alcohol-dependent individuals have greater hypothalamic-pituitary-adrenal axis activation induced by naloxone compared with offspring without a family history of alcohol dependence. Alcohol Clin. Exp. Res. 25:2001;1134-1139.
62. Wand G.S., McCaul M., Yang X., Reynolds J., Gotjen D., Lee S., Ali A. The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induce by opioid receptor blockade. Neuropsychopharmacology. 26:2002;106-114.
63. Yajima F., Suda T., Tomori N., Sumitomo T., Nakagami Y., Ushiyama T., Demura H., Shizume K. Effects of opioid peptides on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro. Life Sci. 39:1986;181-186.
64. Zorrilla E.P., DeRubeis F.J., Redei E. High self-esteem, hardiness, and affective stability are associated with higher basal pituitary-adrenal hormone levels. Psychoneuroendocrinology. 20:1995;591-601.